The anticancer activity of 3- and 10-bromofascaplysins is mediated by caspase-8, -9, -3-dependent apoptosis

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 11, 2010, Pages 3834-3840

  Kuzmich, Alexandra S ^a   Fedorov, Sergey N ^a   Shastina, Valeria V ^a   Shubina, Larisa K ^a   Radchenko, Oleg S ^a   Balaneva, Nadezda N ^a   Zhidkov, Maxim E ^b   Park, Joo In ^c   Kwak, Jong Y ^c   Stonik, Valentin A ^a  

^a PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b FAR EASTERN FEDERAL UNIVERSITY   (Russian Federation)

^c Dong A University   (South Korea)

Author keywords

3 and 10 Bromofascaplysins; Apoptosis; Cancer preventive; p53, AP 1 nuclear factors

Indexed keywords

10 BROMOFASCAPLYSIN; 3 BROMOFASCAPLYSIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; LUCIFERASE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL ASSAY; CELL LINE; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL PERMEABILITY; MOUSE; NONHUMAN; SKIN EPITHELIUM; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MICE; MITOCHONDRIA; PERMEABILITY; SKIN;

EID: 77953127785     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.04.043     Document Type: Article

References (65)

1. Roll D.M., Ireland C.M., Lu H.S.M., and Clardy J. J. Org. Chem. 53 (1988) 3276
2. Soni R., Muller L., Furet P., Schoepfer J., Stephan C., Zumstein-Mecker S., Fretz H., and Chaudhuri B. Biochem. Biophys. Res. Commun. 275 (2000) 877
3. Segraves N.L., Lopez S., Johnson T.A., Said S.A., Fu X., Schmitz F.J., Pietraszkiewicz H., Valeriote F.A., and Crews P. Tetrahedron Lett. 44 (2003) 3471
4. Segraves N.L., Robinson S.J., Garcia D., Said S.A., Fu X., Schmitz F.J., Pietraszkiewicz H., Valeriote F.A., and Crews P. J. Nat. Prod. 67 (2004) 783
5. Zhidkov M.E., Baranova O.V., Balaneva N.N., Fedorov S.N., Radchenko O.S., and Dubovitskii S.V. Tetrahedron Lett. 48 (2007) 7998
6. Charan R.D., McKee T.C., Gustafson K.R., Pannell L.K., and Boyd M.R. Tetrahedron Lett. 43 (2002) 5201
7. Aubry C., Jenkins P.R., Mahale S., Chaudhuri B., and Sutcliffe M.J. Chem. Commun. (2004) 1696
8. Popov A.M., Makarieva T.N., Fedoreev S.A., and Stonik V.A. Chemother. Tumors USSR (Rus.) 56 (1991) 61
9. Delmas D., Lancon A., Colin D., Jannin B., and Latruffe N. Curr. Drug Targets 7 (2006) 423
10. Lu Y.P., Low Y.R., Xie J.G., Peng Q.Y., Liao I., Yang C.S., and Huang M.T. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12455
11. Rogozin E.A., Lee K.W., Kang N.J., Yu H., Nomura M., Miyamoto K.I., Conney A.H., Bode A.M., and Dong Z. Carcinogenesis 29 (2008) 1228
12. Fedorov S.N., Bode A.M., Stonik V.A., Gorshkova I.A., Schmid P.C., Radchenko O.S., Berdyshev E.V., and Dong Z. Pharm. Res. 21 (2004) 2307
13. Fedorov S.N., Shubina L.K., Bode A.M., Stonik V.A., and Dong Z. Cancer Res. 67 (2007) 5914
14. Fedorov S.N., Shubina L.K., Kicha A.A., Ivanchina N.V., Kwak J.Y., Jin J.O., Bode A.M., Dong Z., and Stonik V.A. Nat. Prod. Commun. 3 (2008) 1575
15. Lee K.W., Kang N.J., Heo Y.S., Rogozin E.A., Pugliese A., Hwang M.K., Bowden G.T., Bode A.M., Lee H.J., and Dong Z. Cancer Res. 68 (2008) 946
16. Colburn N.H., Former B.F., Nelson K.A., and Yuspa S.H. Nature 281 (1979) 589
17. Dong Z., Birrer M.J., Watts R.G., Matrisian L.M., and Colburn N.H. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 609
18. Dong Z., Watts R.G., Sun Y., and Colburn N.H. Int. J. Oncol. 7 (1995) 359
19. Strickland J., Sun Y., Dong Z., and Colburn N.H. Carcinogenesis 18 (1997) 1135
20. Baltrop J.A., Owen T.C., Cory A.H., and Cory J.G. Bioorg. Med. Chem. Lett. 1 (1991) 611
21. Hocker T.L., Singh M.K., and Tsao H. J. Invest. Dermatol. 128 (2008) 2575
22. Soengas M.S., and Lowe S.W. Oncogene 22 (2003) 3138
23. Hengartner M.O. Nature 407 (2000) 770
24. Sun S.-Y., Hail Jr. N., and Lotan R. J. Natl. Cancer Inst. 96 (2004) 662
25. Chang H.Y., and Yang X. Microbiol. Mol. Biol. Rev. 64 (2000) 821
26. Stennicke H.R., and Salvesen G.S. Biochim. Biophys. Acta 1387 (1998) 17
27. Dias N., and Bailly C. Biochem. Pharmacol. 70 (2005) 1
28. Li H., Zhu H., Xu C.J., and Yuan J. Cell 94 (1998) 491
29. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Cell 94 (1998) 481
30. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Annu. Rev. Cell Dev. Biol. 15 (1999) 269
31. Levine A.J. Cell 88 (1997) 323
32. Prives C., and Hall P.A. J. Pathol. 187 (1999) 112
33. Vousden K.H. Cell 103 (2000) 691
34. Huang C., Ma W.Y., Goranson A., and Dong Z. Carcinogenesis 20 (1999) 237
35. Qin J., Chen H.-G., Yan Q., Deng M., Liu J., Doerge S., Ma W., Dong Z., and Li D.W. Cancer Res. 68 (2008) 4150
36. He Z., Ma W.-Y., Hashimoto T., Bode A.M., Yang C.S., and Dong Z. Cancer Res. 63 (2003) 4396
37. Schmidt F., Knobbe C.B., Frank B., Wolburg H., and Weller M. Oncol. Rep. 19 (2008) 1061
38. Choudhury S.R., Karmakar S., Banik N.L., and Ray S.K. Invest. New Drugs (2009) 10.1007/s10637-009-9324-7
39. Park Y.J., Wen J., Bang S., Park S.W., and Song S.Y. Yonsei Med. J. 47 (2006) 688
40. Tsvetkov P., Asher G., Reiss V., Shaul Y., Sachs L., and Lotem J. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5535
41. Fedorov S.N., Radchenko O.S., Shubina L.K., Balaneva N.N., Bode A.M., Stonik V.A., and Dong Z. Pharm. Res. 23 (2006) 70
42. Wang L., Shen Y., Song R., Sun Y., Xu J., and Xu Q. Mol. Pharm. 76 (2009) 1238
43. Watson J.L., Greenshields A., Hill R., Hilchie A., Lee P.W., Giacomantonio C.A., and Hoskin D.W. Mol. Carcinog. (2009) 10.1002/mc.20571
44. Regula K.M., and Kirshenbaum L.A. J. Mol. Cell. Cardiol. 33 (2001) 1435
45. Marchenko N.D., and Moll U.M. Cell Cycle 6 (2007) 1718
46. Wolff S., Erster S., Palacios J., and Moll U.M. Cell Res. 18 (2008) 733
47. Marchenko N.D., Zaika A., and Moll U.M. J. Biol. Chem. 275 (2000) 16202
48. Dong Z., Lavrovsky V., and Colburn N.H. Carcinogenesis 16 (1995) 749
49. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., and Colburn N. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 9827
50. Chiu R., Angel P., and Karin M. Cell 59 (1989) 979
51. Passegue E., Jochum W., Schorpp-Kistner M., Mohle-Steinlein U., and Wagner E.F. Cell 104 (2001) 21
52. Le-Niculescu H., Bonfoco E., Kasuya Y., Claret F.X., Green D.R., and Karin M. Mol. Cell. Biol. 19 (1999) 751
53. Kondo T., Matsuda T., Kitano T., Takahashi A., Tashima M., Ishikura H., Umehara H., Domae N., Uchiyama T., and Okazaki T. J. Biol. Chem. 275 (2000) 7668
54. Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., and Green D.R. Mol. Cell 1 (1998) 543
55. Manna S.K., Sah N.K., and Aggarwal B.B. J. Biol. Chem. 275 (2000) 1329
56. Fan M., Goodwin M.E., Birrer M.J., and Chambers T.C. Cancer Res. 61 (2001) 4450
57. Zhu B.K., Wang P., Zhang X.D., Jiang C.C., Chen L.H., Avery-Kiejda K.A., Watts R., and Hersey P. Anticancer Drugs 19 (2008) 189
58. Rogozin E.A., Urazova L.N., and Serebrov V.Y. Bulletin SO RAMS (Rus.) 108 (2003) 121
59. Kyriakis J.M., and Avruch J. Physiol. Rev. 81 (2001) 807
60. Ballif B.A., and Blenis J. Cell Growth Differ. 12 (2001) 397
61. Rubinfeld H., and Seger R. Mol. Biotechnol. 31 (2005) 151
62. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., and Greenberg M.E. Science 286 (1999) 1358
63. Davis R. Cell 103 (2000) 239
64. Weston C.R., and Davis R.J. Curr. Opin. Cell Biol. 19 (2007) 142
65. Huang C., Ma W.-Y., Young M.R., Colburn N., and Dong Z. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 156